Pluristem Life Systems Inc.
Edit Page
Report
Scan day: 17 February 2014 UTC
30
Virus safety - good
Description: Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel.
Pluristem Therapeutics Inc. - Home Pluristem CEO Zami Aberman to Speak on Panel at 9th Annual Stem Cell Summit on February 18, 2014 Medical Key Opinion Leaders in Preeclampsia Join Pluristem’s Steering Committee
Size: 211 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Pluristem Therapeutics Inc. - Home |
| Keywords: | TechnologyR&D CenterClinical ProgramInvestorsContact UsAboutManagement TeamPress ReleasesPluristem in the MediaPlacenta |
| Description: | Pluristem Therapeutics Inc. is a biotechnology company that is developing off-the-shelf cell therapies for a variety of human diseases. |
| IP-address: | 173.254.28.57 |
WHOIS Info
| NS | Name Server: DNS.INTER.NET.IL Name Server: DNS2.INTER.NET.IL |
| WHOIS | Status: clientDeleteProhibited Status: clientTransferProhibited |
| Date | Creation Date: 20-feb-2003 Expiration Date: 20-feb-2015 |